These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 34086412)

  • 1. Tensin 1 (TNS1) is a modifier gene for low body mass index (BMI) in homozygous [F508del]CFTR patients.
    Walton NI; Zhang X; Soltis AR; Starr J; Dalgard CL; Wilkerson MD; Conrad D; Pollard HB
    Physiol Rep; 2021 Jun; 9(11):e14886. PubMed ID: 34086412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and Safety of CFTR Corrector and Potentiator Combination Therapy in Patients with Cystic Fibrosis for the F508del-CFTR Homozygous Mutation: A Systematic Review and Meta-analysis.
    Wu HX; Zhu M; Xiong XF; Wei J; Zhuo KQ; Cheng DY
    Adv Ther; 2019 Feb; 36(2):451-461. PubMed ID: 30554331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corrector therapies (with or without potentiators) for people with cystic fibrosis with class II CFTR gene variants (most commonly F508del).
    Southern KW; Murphy J; Sinha IP; Nevitt SJ
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD010966. PubMed ID: 33331662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cystic fibrosis transmembrane conductance regulator (CFTR) allelic variants relate to shifts in faecal microbiota of cystic fibrosis patients.
    Schippa S; Iebba V; Santangelo F; Gagliardi A; De Biase RV; Stamato A; Bertasi S; Lucarelli M; Conte MP; Quattrucci S
    PLoS One; 2013; 8(4):e61176. PubMed ID: 23613805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restoration of CFTR function in patients with cystic fibrosis carrying the F508del-CFTR mutation.
    De Stefano D; Villella VR; Esposito S; Tosco A; Sepe A; De Gregorio F; Salvadori L; Grassia R; Leone CA; De Rosa G; Maiuri MC; Pettoello-Mantovani M; Guido S; Bossi A; Zolin A; Venerando A; Pinna LA; Mehta A; Bona G; Kroemer G; Maiuri L; Raia V
    Autophagy; 2014; 10(11):2053-74. PubMed ID: 25350163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High frequency of complex CFTR alleles associated with c.1521_1523delCTT (F508del) in Russian cystic fibrosis patients.
    Petrova NV; Kashirskaya NY; Vasilyeva TA; Balinova NV; Marakhonov AV; Kondratyeva EI; Zhekaite EK; Voronkova AY; Kutsev SI; Zinchenko RA
    BMC Genomics; 2022 Apr; 23(1):252. PubMed ID: 35365085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA sequencing analysis of cystic fibrosis transmembrane conductance regulator gene identifies cystic fibrosis-associated variants in the Severe Asthma Research Program.
    Izquierdo ME; Marion CR; Moore WC; Raraigh KS; Taylor-Cousar JL; Cutting GR; Ampleford E; Hawkins GA; Zein J; Castro M; Denlinger LC; Erzurum SC; Fahy JV; Israel E; Jarjour NN; Mauger D; Levy BD; Wenzel SE; Woodruff P; Bleecker ER; Meyers DA; Ortega VE
    Pediatr Pulmonol; 2022 Jul; 57(7):1782-1788. PubMed ID: 35451201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correctors (specific therapies for class II CFTR mutations) for cystic fibrosis.
    Southern KW; Patel S; Sinha IP; Nevitt SJ
    Cochrane Database Syst Rev; 2018 Aug; 8(8):CD010966. PubMed ID: 30070364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cystic Fibrosis Gene Mutation Frequency Among a Group of Suspected Children in King Hussein Medical Center.
    Al-Abadi B; Al-Hiary M; Khasawneh R; Al-Momani A; Bani-Salameh A; Al-Saeidat S; Al-Khlaifat A; Aboalsondos O
    Med Arch; 2019 Apr; 73(2):118-120. PubMed ID: 31391700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genes in the vicinity of CFTR modulate the cystic fibrosis phenotype in highly concordant or discordant F508del homozygous sib pairs.
    Mekus F; Laabs U; Veeze H; Tümmler B
    Hum Genet; 2003 Jan; 112(1):1-11. PubMed ID: 12483292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical phenotype of cystic fibrosis patients with the G551D mutation.
    Comer DM; Ennis M; McDowell C; Beattie D; Rendall J; Hall V; Elborn JS
    QJM; 2009 Nov; 102(11):793-8. PubMed ID: 19734299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced expression of Tis7/IFRD1 protein in murine and human cystic fibrosis airway epithelial cell models homozygous for the F508del-CFTR mutation.
    Blanchard E; Marie S; Riffault L; Bonora M; Tabary O; Clement A; Jacquot J
    Biochem Biophys Res Commun; 2011 Aug; 411(3):471-6. PubMed ID: 21723850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An association study on contrasting cystic fibrosis endophenotypes recognizes KRT8 but not KRT18 as a modifier of cystic fibrosis disease severity and CFTR mediated residual chloride secretion.
    Stanke F; Hedtfeld S; Becker T; Tümmler B
    BMC Med Genet; 2011 May; 12():62. PubMed ID: 21548936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genes that determine immunology and inflammation modify the basic defect of impaired ion conductance in cystic fibrosis epithelia.
    Stanke F; Becker T; Kumar V; Hedtfeld S; Becker C; Cuppens H; Tamm S; Yarden J; Laabs U; Siebert B; Fernandez L; Macek M; Radojkovic D; Ballmann M; Greipel J; Cassiman JJ; Wienker TF; Tümmler B
    J Med Genet; 2011 Jan; 48(1):24-31. PubMed ID: 20837493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of IVS6A GATT polymorphism of CFTR gene with cystic fibrosis: first study in CF and normal Tunisian population.
    Chaima S; Sondess HF; Khedija B; Ahmed M; Taieb M
    Ann Biol Clin (Paris); 2020 Jun; 78(3):314-318. PubMed ID: 32540817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Five percent of normal cystic fibrosis transmembrane conductance regulator mRNA ameliorates the severity of pulmonary disease in cystic fibrosis.
    Ramalho AS; Beck S; Meyer M; Penque D; Cutting GR; Amaral MD
    Am J Respir Cell Mol Biol; 2002 Nov; 27(5):619-27. PubMed ID: 12397022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genotype patterns for mutations of the cystic fibrosis transmembrane conductance regulator gene: a retrospective descriptive study from Saudi Arabia.
    Banjar HH; Tuleimat L; El Seoudi AAA; Mogarri I; Alhaider S; Nizami IY; AlMaghamsi T; Alkaf SA; Moghrabi N
    Ann Saudi Med; 2020; 40(1):15-24. PubMed ID: 32026723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological Correction of Cystic Fibrosis: Molecular Mechanisms at the Plasma Membrane to Augment Mutant CFTR Function.
    Arora K; Naren AP
    Curr Drug Targets; 2016; 17(11):1275-81. PubMed ID: 26648081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Augmentation of Cystic Fibrosis Transmembrane Conductance Regulator Function in Human Bronchial Epithelial Cells via SLC6A14-Dependent Amino Acid Uptake. Implications for Treatment of Cystic Fibrosis.
    Ahmadi S; Wu YS; Li M; Ip W; Lloyd-Kuzik A; Di Paola M; Du K; Xia S; Lew A; Bozoky Z; Forman-Kay J; Bear CE; Gonska T
    Am J Respir Cell Mol Biol; 2019 Dec; 61(6):755-764. PubMed ID: 31189070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extent of rescue of F508del-CFTR function by VX-809 and VX-770 in human nasal epithelial cells correlates with SNP rs7512462 in SLC26A9 gene in F508del/F508del Cystic Fibrosis patients.
    Kmit A; Marson FAL; Pereira SV; Vinagre AM; Leite GS; Servidoni MF; Ribeiro JD; Ribeiro AF; Bertuzzo CS; Amaral MD
    Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1323-1331. PubMed ID: 30716472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.